Diabetic neuropathy: Therapies for peripheral and autonomic symptoms

Geriatrics

Volumn 52, Issue 4, 1997, Pages 40-50

  Emanuele, Nicholas V ^a   Emanuele, Mary Ann ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMITRIPTYLINE; ANALGESIC AGENT; BETHANECHOL; CAPSAICIN; CARBAMAZEPINE; CISAPRIDE; FLUDROCORTISONE; GABAPENTIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED PROTEIN; IMIPRAMINE; LIDOCAINE; METOCLOPRAMIDE; MEXILETINE; MIDODRINE; NARCOTIC ANALGESIC AGENT; SORBITOL; TOLRESTAT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADRENAL MEDULLA; BLADDER DYSFUNCTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEUROPATHY; GASTROINTESTINAL DISEASE; HUMAN; PAIN; PROTEIN GLYCOSYLATION; PUPIL DISEASE; REVIEW; SKIN MANIFESTATION; SOMNOLENCE; SWEAT GLAND DISEASE; VERTIGO;

EID: 0031410397     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-88.
2. Abraira C, Emanuele N, Colwell J, et al. VA Cooperative Study Group: Glycemic control and complications in type II diabetes: Design of a feasibility trial. Diabetes Care, 1992; 15:1560-71.
3. Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987; 147:1442-4.
4. Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA 1984; 251 (13):1727-30.
5. Gomez-Perez FJ, Rull JA, Dies H, Rodriquez-Rivera JG, Gonzalez-Barranco J, Lozano-Castaneda O. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double- blind cross-over study. Pain 1985; 23: 395-400.
6. Mendel CM, Klein RF, Chappel DA, et al. A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy. JAMA 1986; 255:637-39.
7. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37:589-96.
8. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990; 42:135-44.
9. Max MB, Lynch SA, Muir J, Shoaf SE, Smaller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326:1250-6.
10. Sindrup SH, Gram LF, Skjold T, Froland A, Beck-Nielsen H. Concentration- response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990; 47:509- 15.
11. Tandon R, Lewis GA, Krusinski PB, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up. Diabetes Care 1992; 15(1):8-14.
12. Capsaicin Study Group: Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992; 15:159-65.
13. Rull JA, Quibrera R, Gonzalez-Millan H, Castaneda OL. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): Double-blind cross-over trial. Diabetologia 1969; 5:215-8.
14. Kastrup J, Petersen P, Dejgard A, Angelo HR, Hilsted J. Intravenous lidocaine infusion: A new treatment of chronic painful diabetic neuropathy? Pain 1987; 28:69- 75.
15. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988; 1:9- 11.
16. Shindo H, Tawata M, Aida K, Onaya T. Clinical efficacy of a stable prostacyclin analog, iloprost, in diabetic neuropathy. Prostaglandins 1991; 41:85-96.
17. Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with γ- linolenic acid. Diabetes Care 1993; 16(1):8-15.
18. Giugliano D, Marfella R, Quatraro A, et al. Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial. Ann Intern Med 1993; 118:7-11.
19. Giugliano D, Acampora R, Marfella R, et al. Tolrestat in the primary prevention of diabetic neuropathy. Diabetes Care 1995; 18(4):536-41.
20. Straub RH, Jeron A, Kerp L. The pupillary light reflex. Prevalence of pupillary autonomic neuropathy in diabetics using age-dependent and age-independent pupillary parameters. Ophthalmologica 1992; 204(3):143-8.
21. Levy DM, Reid G, Rowley DA, Abraham RR. Quantitative measures of sympathetic skin response in diabetes: Relation to sudomotor and neurological function. J Neurol Neurosurg Psych 1992; 55(10): 902-8.
22. Werth B, Meyer-Wyss B, Spinas GA, Drewe J, Beglinger C. Non-invasive assessment of gastrointestinal motility disorders in diabetic patients with and without cardiovascular signs of autonomic neuropathy. Gut 1992; 33(9):1199- 203.
23. Ishii M, Nakamura T, Kasai F, Onuma T, Baba T, Takebe K. Altered postprandial insulin requirement in IDDM patients with gastroparesis. Diabetes Care 1994; 17(8):901-3.
24. Kawagishi T, Nishizawa Y, Okuno Y, Sekiya K, Morii H. Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy. Am J Gastroenterol 1993; 88(6):933-8.
25. Schmid R, Schusdziarra V, Allescher HD, Bofilias I, Butterman G, Glassen M. Effect of motilin on gastric emptying in patients with diabetic gastroparesis. Diabetes Care 1991; 14(1):65-8.
26. Nakabayashi H, Fujii S, Miwa U, Seta T, Takeda R. Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide. Arch Intern Med 1994; 154(16):1863-7.
27. Kaiser FE, Korenman SG. Impotence in diabetic men. Am J Med 1988; 85(5A): 147-52.
28. Cryer PE, White NH, Santiago JV. The relevance of glucose counterregulatory systems to patients with insulin-independent diabetes mellitus. Endocrine Rev 1986; 7(2):131-9.
29. Hoeldtke RD, Boden G. Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med 1994; 120(6):512-7.
30. Gert van Dijk J, Tjon-A-Tsien AM, Kamzoul BA, Kramer CG, Lemkes HH. Effects of supine blood pressure on interpretation of standing up test in 500 patients with diabetes mellitus. J Auton Nerv Syst 1994; 47(1-2):23-31.
31. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzoxi MG. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. J Am Coll Cardiol 1993; 22(7):1788-94.